Indication
Apnea
3 clinical trials
7 products
1 drug
Clinical trial
Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients. A Cohort StudyStatus: Recruiting, Estimated PCD: 2024-03-30
Product
Influvac TetraClinical trial
A Prospective, Randomized, Open-label Clinical Trial to Assess Apnea Following Administration of 13-valent Conjugate Pneumococcal Vaccine, Diphtheria Toxoid, Tetanus Toxoid, and Acellular Pertussis Vaccine, Inactivated Polio Vaccine, Hepatitis B Vaccine, and Haemophilus Influenzae Type B Vaccine in Preterm InfantsStatus: Completed, Estimated PCD: 2021-11-01
Product
PCV13Product
DTaPProduct
HBVProduct
IPVProduct
HibClinical trial
PILOT STUDY OF THE EFFECT OF A SUBSTANCE P ANTAGONIST, APREPITANT, ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME AND ARTERIAL HYPERTENSIONStatus: Recruiting, Estimated PCD: 2026-04-19
Product
AprepitantDrug
Varlilumab